Table 1
Component costs per 1,000 women over a lifetime, by screening strategy (no discount)

Table 1
Component costs per 1,000 women over a lifetime, by screening strategy (no discount)
Table summary
This table displays the results of Component costs per 1. The information is grouped by Screening strategy (appearing as row headers), Screening , Diagnostic and clinical work-up , Surgical and radiation , Adjuvant medication, Indirect (based on lost productivity), Overall cost and Additional cost of premature death (appearing as column headers).
Screening strategy Screening Diagnostic and clinical work-up Surgical and radiation Adjuvant medicationNote † Indirect (based on lost productivity) Overall cost Additional cost of premature death
No Screening $0 $83,936 $1,220,608 $1,713,473 $1,856,569 $4,874,587 $12,671,495
Annual ages 40 to 69 $6,540,531 $40,605 $1,530,563 $1,694,982 $4,864,284 $14,670,965 $6,180,986
Annual ages 40 to 74 $7,314,735 $30,529 $1,618,139 $1,707,003 $5,322,003 $15,992,409 $5,794,587
Annual ages 50 to 69 $4,127,472 $47,245 $1,487,568 $1,713,469 $3,904,655 $11,280,409 $7,847,010
Annual ages 50 to 74 $4,908,452 $37,013 $1,575,399 $1,724,528 $4,364,947 $12,610,339 $7,408,591
Biennial ages 50 to 69 $2,175,956 $55,863 $1,437,689 $1,807,948 $3,019,322 $8,496,778 $9,261,094
Biennial ages 50 to 74 $2,672,157 $46,018 $1,524,021 $1,849,832 $3,350,174 $9,442,203 $8,866,323
Triennial ages 50 to 69 $1,573,325 $61,405 $1,406,127 $1,821,409 $2,724,921 $7,587,187 $10,085,986
Triennial ages 50 to 74 $1,911,210 $53,721 $1,477,251 $1,864,335 $2,964,934 $8,271,452 $9,778,164
Annual ages 40 to 49/ Biennial ages 50 to 69 $4,551,101 $49,334 $1,479,841 $1,788,107 $3,985,553 $11,853,937 $7,552,892
Annual ages 40 to 49/Biennial ages 50 to 74 $5,027,968 $39,529 $1,567,832 $1,832,766 $4,316,621 $12,784,716 $7,130,482
Annual ages 40 to 49 $2,484,365 $75,590 $1,276,581 $1,705,534 $2,848,195 $8,390,266 $10,795,828
Note †

adjuvant chemotherapy, hormonal therapies (for example, tamoxifen, aromatase inhibitors) and traztusumab

Return to note † referrer

Source: Canadianized University of Wisconsin Breast Cancer Epidemiology Simulation Model.

More information

ISSN: 1209-1367

Note of appreciation

Canada owes the success of its statistical system to a long-standing partnership between Statistics Canada, the citizens of Canada, its businesses, governments and other institutions. Accurate and timely statistical information could not be produced without their continued co-operation and goodwill.

Standards of service to the public

Statistics Canada is committed to serving its clients in a prompt, reliable and courteous manner. To this end, the Agency has developed standards of service which its employees observe in serving its clients.

Copyright

Published by authority of the Minister responsible for Statistics Canada.

© 2015 Minister of Industry

Permission is granted for non-commercial reproduction related to educational purposes, provided there is a clear acknowledgement of the source. Otherwise, no part of this publication may be reproduced or transmitted in any form without prior permission from the Canadian Education Statistics Council, 95 St. Clair Ave. West, Suite 1106, Toronto, Ontario, M4V 1N6.

close
Date modified: